Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

2016 ASCO Annual Meeting

3 - 7 Jun 2016
McCormick Place, Chicago, United States of America
Editor's ASCO 2016 Roundup
Prof Gordon McVie - ecancer Editor in Chief
Editor's ASCO 2016 Roundup ( Prof Gordon McVie - ecancer Editor in Chief )
16 Jun 2016
Inpatient palliative care intervention in patients hospitalized for HSCT
Dr Areej El-Jawahri - Massachusetts General Hospital, Boston, USA
Inpatient palliative care intervention in patients hospitalized for HSCT ( Dr Areej El-Jawahri - Massachusetts General Hospital, Boston, USA )
16 Jun 2016
Latest in precision cancer medicine
Prof Richard Schilsky - Chief Medical Officer, ASCO
Latest in precision cancer medicine ( Prof Richard Schilsky - Chief Medical Officer, ASCO )
15 Jun 2016
ASCO 2016: Current treatment approaches for advanced prostate cancer
Prof Przemyslaw Twardowski and Prof Gordon McVie
ASCO 2016: Current treatment approaches for advanced prostate cancer ( Prof Przemyslaw Twardowski and Prof Gordon McVie )
7 Jun 2016
The value and strategy for incorporating biosimilars Into clinical practice
Dr Francisco Esteva - New York University, New York, USA
The value and strategy for incorporating biosimilars Into clinical practice ( Dr Francisco Esteva - New York University, New York, USA )
7 Jun 2016
Checkpoint inhibitor therapy benefits advanced bladder cancer patients
Dr Arjun Vasant Balar - NYU Langone Medical Center, New York, USA
Checkpoint inhibitor therapy benefits advanced bladder cancer patients ( Dr Arjun Vasant Balar - NYU Langone Medical Center, New York, USA )
7 Jun 2016
Neuroblastoma outcomes improved with second stem cell transplant
Dr Julie Park - Seattle Children's Hospital, Seattle, USA
Neuroblastoma outcomes improved with second stem cell transplant ( Dr Julie Park - Seattle Children's Hospital, Seattle, USA )
6 Jun 2016
Adjuvant docetaxel fails after radical prostatectomy for high risk prostate canc...
Dr Goran Ahlgren - Lund University, Malmö, Sweden
Adjuvant docetaxel fails after radical prostatectomy for high risk prostate cancer ( Dr Goran Ahlgren - Lund University, Malmö, Sweden )
6 Jun 2016
Sequencing analysis with circulating DNA
Dr Oliver Zill - Guardant Health Inc, Brentwood City, USA
Sequencing analysis with circulating DNA ( Dr Oliver Zill - Guardant Health Inc, Brentwood City, USA )
6 Jun 2016
Consolidative therapy extends PFS for NSCLC patients
Prof Daniel Richard Gomez - University of Texas MD Anderson Cancer Center, Houst...
Consolidative therapy extends PFS for NSCLC patients ( Prof Daniel Richard Gomez - University of Texas MD Anderson Cancer Center, Houston, USA )
6 Jun 2016
Preliminary results from KEYNOTE-055: pembrolizumab in HNSCC
Dr Joshua Bauml - University of Pennsylvania, Philadelphia, USA
Preliminary results from KEYNOTE-055: pembrolizumab in HNSCC ( Dr Joshua Bauml - University of Pennsylvania, Philadelphia, USA )
6 Jun 2016
Targetting PD-L1 with avelumab in metastatic Merkel cell carcinoma
Dr Howard Kaufman - Rutgers Cancer Institute of New Jersey, USA
Targetting PD-L1 with avelumab in metastatic Merkel cell carcinoma ( Dr Howard Kaufman - Rutgers Cancer Institute of New Jersey, USA )
6 Jun 2016
Cochlear sparing via intensity modulated radiotherapy
Dr Chris Nutting - Royal Marsden Hospital, London, UK
Cochlear sparing via intensity modulated radiotherapy ( Dr Chris Nutting - Royal Marsden Hospital, London, UK )
6 Jun 2016
Ten years of letrozole improves survival and quality of life in early-diagnosed ...
Dr Julie Lemieux - Hôpital du Saint-Sacrement, Québec, Canada
Ten years of letrozole improves survival and quality of life in early-diagnosed breast cancer. ( Dr Julie Lemieux - Hôpital du Saint-Sacrement, Québec, Canada )
6 Jun 2016
Daratumumab slows progression in refractory multiple myeloma
Prof Palumbo - University of Turin, Turin, Italy
Daratumumab slows progression in refractory multiple myeloma ( Prof Palumbo - University of Turin, Turin, Italy )
6 Jun 2016
Developments in haematological malignancies
Dr Stephen Nimer - University of Miami, Miami, USA
Developments in haematological malignancies ( Dr Stephen Nimer - University of Miami, Miami, USA )
6 Jun 2016
Early integrated palliative care to improve family caregivers outcomes
Dr Areej El-Jawahri - Massachusetts General Hospital, Boston, USA
Early integrated palliative care to improve family caregivers outcomes ( Dr Areej El-Jawahri - Massachusetts General Hospital, Boston, USA )
6 Jun 2016
Recent developments in targeted therapies
Dr Stephen Nimer - University of Miami, Miami, USA
Recent developments in targeted therapies ( Dr Stephen Nimer - University of Miami, Miami, USA )
6 Jun 2016
First results of a prospective bendamustine/rituximab trial in patients with MCL
Dr Mathias Rummel - University of Giessen, Giessen, Germany
First results of a prospective bendamustine/rituximab trial in patients with MCL ( Dr Mathias Rummel - University of Giessen, Giessen, Germany )
6 Jun 2016
Performance characteristics and stage distribution of invasive epithelial ovaria...
Prof Usha Menon - University College London, London, UK
Performance characteristics and stage distribution of invasive epithelial ovarian/tubal/peritoneal cancers ( Prof Usha Menon - University College London, London, UK )
6 Jun 2016
MyPathway guidance of targeted therapy based on molecular profiles
Dr John Hainsworth - Sarah Cannon Research Institute, Nashville, USA
MyPathway guidance of targeted therapy based on molecular profiles ( Dr John Hainsworth - Sarah Cannon Research Institute, Nashville, USA )
6 Jun 2016
Testing the safety and efficacy of the PD-L1 antibody durvalumab
Dr Christophe Massard - Institut Gustave Roussy, Paris, France
Testing the safety and efficacy of the PD-L1 antibody durvalumab ( Dr Christophe Massard - Institut Gustave Roussy, Paris, France )
6 Jun 2016
Upfront autologous stem cell transplantation for newly diagnosed multiple myelom...
Prof Michele Cavo - Seràgnoli Institute of Hematology, Bologna, Italy
Upfront autologous stem cell transplantation for newly diagnosed multiple myeloma ( Prof Michele Cavo - Seràgnoli Institute of Hematology, Bologna, Italy )
6 Jun 2016
Subset of anaplastic glioma patients benefit from adjuvant chemo
Dr Martin van den Bent - Erasmus MC Cancer Center, Rotterdam, The Netherlands
Subset of anaplastic glioma patients benefit from adjuvant chemo ( Dr Martin van den Bent - Erasmus MC Cancer Center, Rotterdam, The Netherlands )
6 Jun 2016
ASCO 2016: What is the optimal chemotherapy dosing regimen for prostate cancer?
Prof Charles Ryan and Prof Nick James
ASCO 2016: What is the optimal chemotherapy dosing regimen for prostate cancer? ( Prof Charles Ryan and Prof Nick James )
6 Jun 2016
Advanced RET-rearranged NSCLC
Dr Takashi Seto and Dr Kiyotaka Yoh
Advanced RET-rearranged NSCLC ( Dr Takashi Seto and Dr Kiyotaka Yoh )
6 Jun 2016
Global drug pricing: How cost-effective is bevacizumab?
Dr Daniel Goldstein - Emory University, Atlanta, USA
Global drug pricing: How cost-effective is bevacizumab? ( Dr Daniel Goldstein - Emory University, Atlanta, USA )
6 Jun 2016
Update on olaparib in ovarian cancer
Prof Jonathan Ledermann - University College Hospital Medical School, London, UK
Update on olaparib in ovarian cancer ( Prof Jonathan Ledermann - University College Hospital Medical School, London, UK )
6 Jun 2016
CPX-351 improves outcomes for refractory AML
Dr Jeffrey Lancet - H. Lee Moffitt Cancer Center, Tampa, USA
CPX-351 improves outcomes for refractory AML ( Dr Jeffrey Lancet - H. Lee Moffitt Cancer Center, Tampa, USA )
6 Jun 2016
ASCO 2016: Accuracy of multi-parametric MRI to predict further investigational b...
Prof Nick James and Prof Charles Ryan
ASCO 2016: Accuracy of multi-parametric MRI to predict further investigational biopsy ( Prof Nick James and Prof Charles Ryan )
6 Jun 2016
Radiotherapy modalities for locally advanced non-small cell lung cancer
Dr Zhongxing Liao - University of Texas MD Anderson Cancer Center, Houston, USA
Radiotherapy modalities for locally advanced non-small cell lung cancer ( Dr Zhongxing Liao - University of Texas MD Anderson Cancer Center, Houston, USA )
6 Jun 2016
First in-human trials of rovalpituzumab for SCLC
Dr Charles Rudin - Memorial Sloan Kettering Cancer Center, New York, USA
First in-human trials of rovalpituzumab for SCLC ( Dr Charles Rudin - Memorial Sloan Kettering Cancer Center, New York, USA )
6 Jun 2016
Impact of precision medicine in refractory malignancies
Prof Maria Schwaederle - University of California, San Diego, USA
Impact of precision medicine in refractory malignancies ( Prof Maria Schwaederle - University of California, San Diego, USA )
6 Jun 2016
ASCO 2016: Highlights in prostate cancer from days 3 and 4
Dr Eleni Efstathiou, Prof Kurt Miller, Dr Chris Parker and Prof Stephane Oudard
ASCO 2016: Highlights in prostate cancer from days 3 and 4 ( Dr Eleni Efstathiou, Prof Kurt Miller, Dr Chris Parker and Prof Stephane Oudard )
6 Jun 2016
Large disparities found in BCRA testing across ethnicities
Dr Tuya Pal - Moffitt Cancer Center, Tampa, USA
Large disparities found in BCRA testing across ethnicities ( Dr Tuya Pal - Moffitt Cancer Center, Tampa, USA )
6 Jun 2016
Surgery in stage 4 breast cancer increased survival
Prof Atilla Soran - University of Pittsburgh, Pennsylvania, USA
Surgery in stage 4 breast cancer increased survival ( Prof Atilla Soran - University of Pittsburgh, Pennsylvania, USA )
6 Jun 2016
Trial shows exercise beneficial for patients undergoing chemotherapy
Dr Ian Kleckner - University of Rochester Medical Center, New York, USA
Trial shows exercise beneficial for patients undergoing chemotherapy ( Dr Ian Kleckner - University of Rochester Medical Center, New York, USA )
6 Jun 2016
Photon vs proton beam therapy: modality in radiotherapy for non-small cell lung ...
Dr Madhusmita Behera - Emory University, Atlanta, USA
Photon vs proton beam therapy: modality in radiotherapy for non-small cell lung cancer ( Dr Madhusmita Behera - Emory University, Atlanta, USA )
6 Jun 2016
Phase I study of sapacitabine and seliciclib in patients with advanced solid tum...
Dr Sara Tolaney - Dana Farber Cancer Institute, Boston, USA
Phase I study of sapacitabine and seliciclib in patients with advanced solid tumours ( Dr Sara Tolaney - Dana Farber Cancer Institute, Boston, USA )
6 Jun 2016
ASCO 2016: Plenary Session Review
Dr Julie Vose - President of ASCO
ASCO 2016: Plenary Session Review ( Dr Julie Vose - President of ASCO )
5 Jun 2016
ASCO 2016: Advances in Prostate Cancer
Prof Karim Fizazi, Prof Maria De Santis, Prof Bertrand Tombal and Dr Mark Beresf...
ASCO 2016: Advances in Prostate Cancer ( Prof Karim Fizazi, Prof Maria De Santis, Prof Bertrand Tombal and Dr Mark Beresford )
5 Jun 2016
Elderly patients with glioblastoma live longer with chemoradiation using temozol...
Prof James Perry - University of Toronto, Toronto, Canada
Elderly patients with glioblastoma live longer with chemoradiation using temozolomide ( Prof James Perry - University of Toronto, Toronto, Canada )
5 Jun 2016
Primary tumour location in metastatic colorectal cancer impacts overall survival
Prof Alan Venook - University of California, San Francisco, USA
Primary tumour location in metastatic colorectal cancer impacts overall survival ( Prof Alan Venook - University of California, San Francisco, USA )
5 Jun 2016
Chemotherapy combination with capecitabine extends survival after pancreatic can...
Prof John Neoptolemos - University of Liverpool, Liverpool, UK
Chemotherapy combination with capecitabine extends survival after pancreatic cancer surgery ( Prof John Neoptolemos - University of Liverpool, Liverpool, UK )
5 Jun 2016
Novel antibody helps patients with advanced gastric cancer live longer
Prof Salah-Eddin Al-Batran - University Cancer Center, Frankfurt, Germany
Novel antibody helps patients with advanced gastric cancer live longer ( Prof Salah-Eddin Al-Batran - University Cancer Center, Frankfurt, Germany )
5 Jun 2016
Antibody drug conjugate shows early promise in small cell lung cancer
Dr Charles Rudin - Memorial Sloan Kettering Cancer Center, New York, USA
Antibody drug conjugate shows early promise in small cell lung cancer ( Dr Charles Rudin - Memorial Sloan Kettering Cancer Center, New York, USA )
5 Jun 2016
Novel antibody helps patients with advanced gastric cancer live longer
Prof Salah-Eddin Al-Batran - University Cancer Center, Frankfurt, Germany
Novel antibody helps patients with advanced gastric cancer live longer ( Prof Salah-Eddin Al-Batran - University Cancer Center, Frankfurt, Germany )
5 Jun 2016
Patients with advanced bladder cancer benefit from anti-PD-L1 immunotherapy
Dr Arjun Balar - NYU Langone Medical Center, New York, USA
Patients with advanced bladder cancer benefit from anti-PD-L1 immunotherapy ( Dr Arjun Balar - NYU Langone Medical Center, New York, USA )
5 Jun 2016
METEOR trial: cabozantinib vs everolimus in advanced renal cell carcinoma
Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA
METEOR trial: cabozantinib vs everolimus in advanced renal cell carcinoma ( Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA )
5 Jun 2016
Extending adjuvant letrozole for 5 years after completing an initial 5 years of ...
Dr Paul Goss - Massachusetts General Hospital Cancer Center, Boston, USA
Extending adjuvant letrozole for 5 years after completing an initial 5 years of aromatase inhibitor therapy alone ( Dr Paul Goss - Massachusetts General Hospital Cancer Center, Boston, USA )
5 Jun 2016
Ten years of hormone therapy reduces breast cancer recurrence without compromisi...
Dr Julie Lemieux - Hôpital du Saint-Sacrement, Québec, Canada
Ten years of hormone therapy reduces breast cancer recurrence without compromising quality of life ( Dr Julie Lemieux - Hôpital du Saint-Sacrement, Québec, Canada )
5 Jun 2016
Elderly patients with glioblastoma live longer with chemoradiation using temozol...
Prof James Perry - University of Toronto, Toronto, Canada
Elderly patients with glioblastoma live longer with chemoradiation using temozolomide ( Prof James Perry - University of Toronto, Toronto, Canada )
5 Jun 2016
Novel daratumumab-based regimen slows multiple myeloma progression
Prof Antonio Palumbo - University of Torina, Turin, Italy
Novel daratumumab-based regimen slows multiple myeloma progression ( Prof Antonio Palumbo - University of Torina, Turin, Italy )
5 Jun 2016
Double stem-cell transplant improves outcomes for children with high-risk neurob...
Dr Julie Park - Seattle Children's Hospital, Seattle, USA
Double stem-cell transplant improves outcomes for children with high-risk neuroblastoma ( Dr Julie Park - Seattle Children's Hospital, Seattle, USA )
5 Jun 2016
Patient engagement in The Metastatic Breast Cancer Project
Dr Nikhil Wagle - Dana-Farber Cancer Institute, Boston, USA
Patient engagement in The Metastatic Breast Cancer Project ( Dr Nikhil Wagle - Dana-Farber Cancer Institute, Boston, USA )
4 Jun 2016
Advanced hepatocellular carcinoma and personalised therapy
Dr Ghassan Abou-Alfa - Memorial Sloan Kettering Cancer Center, New York, USA
Advanced hepatocellular carcinoma and personalised therapy ( Dr Ghassan Abou-Alfa - Memorial Sloan Kettering Cancer Center, New York, USA )
4 Jun 2016
Latest in hepatocellular carcinoma treatments
Dr Ghassan Abou-Alfa - Memorial Sloan Kettering Cancer Center, New York, USA
Latest in hepatocellular carcinoma treatments ( Dr Ghassan Abou-Alfa - Memorial Sloan Kettering Cancer Center, New York, USA )
4 Jun 2016
Intraperitoneal chemotherapy slows ovarian cancer progression
Dr Helen Mackay - Sunnybrook Research Institute, Toronto, Canada
Intraperitoneal chemotherapy slows ovarian cancer progression ( Dr Helen Mackay - Sunnybrook Research Institute, Toronto, Canada )
4 Jun 2016
Liquid biopsy may help guide treatment decisions for advanced solid tumours
Prof Philip Mack - University of California Davis, Davis, USA
Liquid biopsy may help guide treatment decisions for advanced solid tumours ( Prof Philip Mack - University of California Davis, Davis, USA )
4 Jun 2016
Innovative direct-to-patient outreach may accelerate breast cancer research
Dr Nikhil Wagle - Dana Farber Cancer Institute, Boston, USA
Innovative direct-to-patient outreach may accelerate breast cancer research ( Dr Nikhil Wagle - Dana Farber Cancer Institute, Boston, USA )
4 Jun 2016
Precision medicine selection with MyPathway for solid tumours
Dr John Hainsworth - Sarah Cannon Research Institute, Nashville, USA
Precision medicine selection with MyPathway for solid tumours ( Dr John Hainsworth - Sarah Cannon Research Institute, Nashville, USA )
4 Jun 2016
Liquid biopsy may help guide treatment decisions for advanced solid tumours
Prof Philip Mack - University of California Davis, Davis, USA
Liquid biopsy may help guide treatment decisions for advanced solid tumours ( Prof Philip Mack - University of California Davis, Davis, USA )
4 Jun 2016
ASCO 2016: Expert discussion on the latest on multiple myeloma
Dr Sagar Lonial and Dr Paul Richardson
ASCO 2016: Expert discussion on the latest on multiple myeloma ( Dr Sagar Lonial and Dr Paul Richardson )
3 Jun 2016
Trial of proposed trastuzumab biosimilar, MYL-1401O vs herceptin
Dr Hope Rugo - University of California, San Francisco, USA
Trial of proposed trastuzumab biosimilar, MYL-1401O vs herceptin ( Dr Hope Rugo - University of California, San Francisco, USA )
3 Jun 2016
Hypo-fractionation of prostate cancer radiotherapy
Dr Charles Catton - Princess Margaret Cancer Centre, Toronto, Canada
Hypo-fractionation of prostate cancer radiotherapy ( Dr Charles Catton - Princess Margaret Cancer Centre, Toronto, Canada )
3 Jun 2016
Controlled phase III trial of adjuvant combination chemotherapy of gemcitabine a...
Prof John P. Neoptolemos - University of Liverpool, Liverpool, UK
Controlled phase III trial of adjuvant combination chemotherapy of gemcitabine and capecitabine, versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma ( Prof John P. Neoptolemos - University of Liverpool, Liverpool, UK )
3 Jun 2016
Randomised double blind phase III safety and efficacy trial of the proposed tras...
Dr Hope Rugo - University of California, San Francisco, USA
Randomised double blind phase III safety and efficacy trial of the proposed trastuzumab biosimilar, MYL-1401O vs. herceptin ( Dr Hope Rugo - University of California, San Francisco, USA )
3 Jun 2016
Phase II study of intraperitoneal versus intravenous chemotherapy following neoa...
Dr Helen Mackay - Sunnybrook Research Institute, Toronto, Canada
Phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer ( Dr Helen Mackay - Sunnybrook Research Institute, Toronto, Canada )
3 Jun 2016
Temozolomide after radiotherapy improves glioma survival
Dr Martin Van Den Bent - Erasmus MC Cancer Center, Rotterdam, The Netherlands
Temozolomide after radiotherapy improves glioma survival ( Dr Martin Van Den Bent - Erasmus MC Cancer Center, Rotterdam, The Netherlands )
3 Jun 2016